prozac

Elderly people with dementia are three times more likely to have an injurious fall if they take antidepressants, according to research published in the British Journal of Clinical Pharmacology.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The association with falls can be seen in people who take low doses of selective serotonin reuptake inhibitors (SSRI) and the risk increases as people take higher doses, says the report. The UK Alzheimer’s Society is now calling for research into alternative treatments for depression that patients can be prescribed.

In a statement, the society commented, "Two thirds of care-home residents have dementia so it is worrying that a common antidepressant, SSRIs, is causing increased risk to people with the condition. More research is now needed to understand why this antidepressant is having this effect on people with dementia and if there is an alternative treatment for depression that they could be prescribed. One in three people over 65 will die with dementia yet research into the condition continues to be drastically underfunded. We must invest now."

Lead author of the study Carolyn Shanty Sterke carried out her research by recording the daily drug use and daily falls in 248 nursing home residents with dementia from 1 January 2006 until 1 January 2008. The incident reports showed that 61% of the residents sustained 683 falls and 220 falls resulted in injury or death. The risk of having an injurious fall increased from an absolute daily risk of 0.09% for a female aged 80 not taking an SSRI, to 0.28% for a female aged 80 taking one defined daily dose of SSRI. Similar increases in absolute daily risk were found for both men and women, for different ages.

She said, "Staff in residential homes are always concerned about reducing the chance of people falling and I think we should consider developing new treatment protocols that take into account the increased risk of falling that occurs when you give people SSRIs."

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Caption: Antidepressents are said to cause increased risk in dementia patients with depression.

Pharmaceutical Technology Excellence Awards - Nominations Closed

Nominations are now closed for the Pharmaceutical Technology Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Awarded the 2025 Pharmaceutical Technology Excellence Award for Business Expansion in Integrated Manufacturing, Upperton Pharma Solutions is rapidly expanding its UK GMP and sterile manufacturing footprint. Find out how Upperton’s integrated CDMO model helps pharma companies move from early development to clinical and niche commercial supply with fewer handovers and faster timelines.

Discover the Impact